Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharmaceutics International Inc
FDA Inspection
•Pharmaceutics International Inc•November 16, 2017

Pharmaceutics International Inc – FDA Inspection, Nov 16, 2017

Record Details

This FDA Inspection record concerns Pharmaceutics International Inc, with an inspection on November 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Pharmaceutics International Inc
Inspection Date
November 16, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • James M. Mason (Issuing Officer)
  • Ko U. Min (FDA Associated Person)
  • Marcus A. Ray (FDA Associated Person)
View Company Profile

ID · c3063d1f-4eb3-45a3-bd4f-fce372d3b590

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1031480
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

10
  1. 21 CFR 211.113(a)Procedures for non-sterile drug products
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.160(b)(3)Drug products-sampling procedures/specifications
  4. 21 CFR 211.160(b)(4)Establishment of calibration procedures
  5. 21 CFR 211.160(b)(4)Test devices not meeting specifications
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.192Written record of investigation incomplete
  8. 21 CFR 211.194(a)Complete test data included in records
  9. 21 CFR 211.194(a)(1)Sample identification and other information
  10. 21 CFR 211.63Equipment Design, Size and Location

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharmaceutics International Inc

13
DateClassificationOfficeProject area
December 6, 2024VAIBaltimore District OfficeDrug Quality Assurance
November 14, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 29, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 9, 2018VAICenter for Drug Evaluation and ResearchNew Drug Evaluation
View all 13 other inspections on the company page
Other documents for Pharmaceutics International Inc
  • FDA Inspection 1251950 - 2024-12-06
  • FDA Inspection 1194130 - 2022-11-14
  • FDA Inspection 1155001 - 2021-09-29
  • FDA Inspection 1124614 - 2020-07-10
  • FDA Inspection 1071297 - 2018-11-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutics International Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.